Marta Casarrubios, PhD

Marta completed her PhD in Madrid, Spain, where she studied the T cell receptor (TCR) repertoire as a biomarker of response to immunotherapy in lung cancer. In the Freed-Pastor laboratory, Marta contributed to multiple projects exploring the antigen landscape of pancreatic cancer.  Marta is now the Chief Scientific Officer (CSO) at Ownmed Innovation. Congratulations Marta!